XML 41 R53.htm IDEA: XBRL DOCUMENT v2.4.0.6
RELATED PARTY TRANSACTIONS (Details) (USD $)
 12 Months Ended 3 Months Ended 3 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2012
Series IV Class B
Dec. 31, 2012
Series V Class B
Dec. 31, 2012
Family members of Chief Executive Officer
Dec. 31, 2011
Family members of Chief Executive Officer
Dec. 31, 2010
Family members of Chief Executive Officer
Dec. 31, 2010
Director
Dec. 31, 2011
Chief Executive Officer
Nov. 04, 2011
Chief Executive Officer
Dec. 31, 2011
Chief Executive Officer
Series IV Class B
Dec. 31, 2011
Chief Executive Officer
Series V Class B
RELATED PARTY TRANSACTIONS                        
Payment for various consulting services and participating in clinical trials         $ 91,086 $ 96,787 $ 75,831 $ 20,350        
Conversion of preferred stock into common stock (in shares) 1,277,464   10,000 1,185,964         86,607      
Amount paid for conversion of preferred stock into common stock 1,357,275 1,357,275 35,000 1,138,525         95,843      
Number of preferred stock shares exchanged against common stock and cash 1,277,464   10,000 1,185,964             5,000 81,607
Waiver of unpaid dividends in arrears                 $ 58,110      
Common stock closing stock price (in dollars per share)                   $ 1.39